EQUILLIUM, INC. Diluted Shares Outstanding (Weighted Average)
EQUILLIUM, INC. (EQ) reported Diluted Shares Outstanding (Weighted Average) of 111.81 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 111.81M shares, a 213.01% increase year-over-year.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 96.28M shares, a 170.55% increase year-over-year.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 92.26M shares, a 160.20% increase year-over-year.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 65.32M shares, a 84.40% increase year-over-year.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 57.30M shares, a 62.07% increase from fiscal 2024.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 35.36M shares, a 1.82% increase from fiscal 2023.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 34.73M shares, a 2.96% increase from fiscal 2022.
- EQUILLIUM, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 33.73M shares, a 17.09% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 111.81M shares 10-Q · filed 2026-08-13 | 104.09M shares 10-Q · filed 2026-08-13 | 100.12M shares derived: average of 3 quarters · filed 2026-08-13 | 91.42M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 96.28M shares 10-Q · filed 2026-05-13 | 94.27M shares derived: average of 2 quarters · filed 2026-05-13 | 84.62M shares derived: average of 3 quarters · filed 2026-05-13 | 72.40M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | 92.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 78.79M shares derived: average of 2 quarters · filed 2026-03-25 | 64.43M shares derived: average of 3 quarters · filed 2026-08-13 | 57.30M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 65.32M shares 10-Q · filed 2025-11-13 | 50.52M shares derived: average of 2 quarters · filed 2026-08-13 | 45.65M shares 10-Q · filed 2025-11-13 | 43.02M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | 35.72M shares 10-Q · filed 2026-08-13 | 35.65M shares 10-Q · filed 2026-08-13 | 35.59M shares derived: average of 3 quarters · filed 2026-08-13 | 35.55M shares derived: average of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 35.59M shares 10-Q · filed 2026-05-13 | 35.52M shares derived: average of 2 quarters · filed 2026-05-13 | 35.49M shares derived: average of 3 quarters · filed 2026-05-13 | 35.76M shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 35.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 35.44M shares derived: average of 2 quarters · filed 2026-03-25 | 35.82M shares derived: average of 3 quarters · filed 2026-03-25 | 35.36M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 35.42M shares 10-Q · filed 2025-11-13 | 36.01M shares derived: average of 2 quarters · filed 2025-11-13 | 35.32M shares 10-Q · filed 2025-11-13 | 35.61M shares derived: average of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | 36.59M shares 10-Q · filed 2025-08-14 | 35.27M shares 10-Q · filed 2025-08-14 | 35.67M shares derived: average of 3 quarters · filed 2025-08-14 | 35.47M shares derived: average of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 35.25M shares 10-Q · filed 2025-05-14 | 35.21M shares derived: average of 2 quarters · filed 2025-05-14 | 35.10M shares derived: average of 3 quarters · filed 2025-05-14 | 34.94M shares derived: average of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 35.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 35.02M shares derived: average of 2 quarters · filed 2025-03-27 | 34.83M shares derived: average of 3 quarters · filed 2025-03-27 | 34.73M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 34.88M shares 10-Q · filed 2024-11-13 | 34.66M shares derived: average of 2 quarters · filed 2024-11-13 | 34.58M shares 10-Q · filed 2024-11-13 | 34.53M shares derived: average of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | 34.45M shares 10-Q · filed 2024-08-08 | 34.43M shares 10-Q · filed 2024-08-08 | 34.41M shares derived: average of 3 quarters · filed 2024-08-08 | 34.40M shares derived: average of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | 34.41M shares 10-Q · filed 2024-05-09 | 34.39M shares derived: average of 2 quarters · filed 2024-05-09 | 34.38M shares derived: average of 3 quarters · filed 2024-05-09 | 34.36M shares derived: average of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 34.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 34.36M shares derived: average of 2 quarters · filed 2024-03-25 | 34.34M shares derived: average of 3 quarters · filed 2024-03-25 | 33.73M shares 10-K · filed 2024-03-25 |
| 2022-09-30 | 34.35M shares 10-Q · filed 2023-11-08 | 34.32M shares derived: average of 2 quarters · filed 2023-11-08 | 33.51M shares 10-Q · filed 2023-11-08 | 32.48M shares derived: average of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | 34.29M shares 10-Q · filed 2023-08-09 | 33.09M shares 10-Q · filed 2023-08-09 | 31.86M shares derived: average of 3 quarters · filed 2023-08-09 | 31.24M shares derived: average of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | 31.87M shares 10-Q · filed 2023-05-11 | 30.64M shares derived: average of 2 quarters · filed 2023-05-11 | 30.22M shares derived: average of 3 quarters · filed 2023-05-11 | 29.94M shares derived: average of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | 29.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 29.40M shares derived: average of 2 quarters · filed 2023-03-23 | 29.29M shares derived: average of 3 quarters · filed 2023-03-23 | 28.81M shares 10-K · filed 2023-03-23 |
| 2021-09-30 | 29.38M shares 10-Q · filed 2022-11-14 | 29.23M shares derived: average of 2 quarters · filed 2022-11-14 | 28.60M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 29.08M shares 10-Q · filed 2022-08-15 | 28.21M shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |